0001415889-23-014675.txt : 20231101 0001415889-23-014675.hdr.sgml : 20231101 20231101175927 ACCESSION NUMBER: 0001415889-23-014675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231030 FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Mark Alan CENTRAL INDEX KEY: 0001532475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 231369438 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoGen, Inc. CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGEN INC DATE OF NAME CHANGE: 19920703 4 1 form4-11012023_091121.xml X0508 4 2023-10-30 0000855654 ImmunoGen, Inc. IMGN 0001532475 Goldberg Mark Alan C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451 true false false false 1 Common Stock 2023-10-30 4 M 0 10000 14.70 A 70151 D Common Stock 2023-10-30 4 M 0 10000 15.08 D 60151 D Stock Option (Right to Buy) 14.70 2023-10-30 4 M 0 10000 0 D 2023-11-12 Common Stock 10000 0 D Effected pursuant to a trading plan adopted on June 9, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.90 to $15.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges. This option was granted on 11/12/2013 and is fully vested as of the transaction date. /s/ Renee Lentini, Attorney-in-Fact 2023-11-01